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We live in changing times—it has always been that way. But, now the times are changing 
more rapidly, dramatically, and unpredictably. The world must accommodate an increasing 
population that demands greater nutrition per person, better health, and greater energy 
consumption per person. As the world’s population rises to a predicted level of nearly 
10 billion by 2050, most want sustainable growth without harm to the environment. 
The inconvenient truth is that it’s not possible with current agricultural, economic, and 
environmental operating systems (Hoekstra and Wiedmann, 2014). The green revolution 
has essentially run its course (Conway and Toenniessen, 2000; Pingali, 2012; Stevenson et 
al., 2013). Even with technological gains, hunger worldwide has been increasing over the 
past decade. Global climate change coupled with a demand for increased nutrition in the 
developing world exacerbates the stress on agricultural production (Eisler and Lee, 2014). 
Hence, developing new methods of increasing the production of agricultural products, 
crops and animals, with minimal impact on the environment is essential (Godfray et al., 
2010). Current approaches cannot meet demands. However, gene editing (Tan et al., 
2012, 2013) (Figure 1)—which allows geneticists to introduce (introgress) any natural 
trait into any breed without the use of recombinant DNA—has the potential of improving 
animal genetics for meeting increasing agricultural and biomedical needs with minimal 
environmental impact. However, there are policy issues associated with gene-editing in 
livestock and in biomedical research that must be addressed for their real-world applications 
(Pauwels et al., 2014). We discuss several types of genome editing and current deficiencies 
in regulatory oversight that block enthusiasm for its adoption to agriculture.
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Genetically modified (GM) animals have been around for more than four decades (Gordon 
and Ruddle, 1981, 1982). These animals had expression cassettes driven by constitutive 
promoters that are active in most cell types and were delivered by vectors that could inte-
grate semi-randomly in genomes (Figure 1, upper panel). As a result, there were fears of 
unacceptable (scary) results (Rollin, 1985) that were exacerbated by the engineering of a 
mouse that grew like a rat (Palmiter et al., 1982, 1983). The first large animals of potential 
commercial importance were fish (Zhu et al., 1986; Hackett and Alvarez, 2000; Devlin 
et al., 2009). Since then, several lines of transgenic livestock have been engineered for 
producing valuable biomedical medicines and for agriculture (Tan et al., 2012). Animals 
engineered to become bioreactors for manufacture of enzymes and antibodies that are not 
for general sale or consumption have been cleared by regulatory authorities. But, in the 
United States, not a single animal engineered for food production has been approved by 
the US Food and Drug Administration (FDA), which regulates GM animals. 
These demonstrations of transgenic technologies were greeted with more concern than 
enthusiasm by the general public and especially by several non-governmental organiza-
tions. The concerns focused on four areas:
• Health effects due to the un-naturalness of products the modified genome might 
encode;
• Environmental effects due to uncontrolled release of transgenes (i.e. GM animals) 
and reduced diversity of natural genomes;
• Social concerns that huge corporations would have undue influence over diets; 
and
• Moral concerns that were summed up by the phrase “playing God.”
These concerns were applied to animals as well as crops.
The first crops were genetically engineered in 1985, e.g. tobacco with a firefly luciferase 
gene (Lamppa et al., 1985). Astonishingly, as shown in Figure 2, over the past 15 years, 
GM crops have been adopted increasingly year after year with respect to acreage, plant 
varieties and countries. In contrast, even though farm animals can be controlled to a far 
greater degree than crops, not a single animal has made it through full regulatory review 
in any country.
This is in part due to the different attitude taken by the FDA, which regulates GM 
animals and the US Department of Agriculture (USDA) and Environmental Protec-
tion Agency (EPA), which regulate GM crops. Foreign countries have in large measure 
deferred to FDA to formulate regulations and procedures for evaluation of GM animals. 
The precision of gene editing along with our greater knowledge of molecular genetics 
and cell biology gained over recent decades supports the belief that GM animals may 
become a reality. 
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Figure 1. Genetic engineering using recombinant DNA vectors compared to genome edit-
ing using site-specific DNAases: The gain in precision between the two methods is 107.
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The Promise of Gene Editing in Animals
Gene-edited animals can be fruitfully employed in three distinct areas, as shown in Figure 3. 
Each of these areas, illustrated in the figure, would be a game-changing event globally 
with respect to personal health. In 2013 in the USA, more than 121,000 individuals 
were on the waiting list for transplantable organs; only 29,000 organs were transplanted. 
However, with precision inactivation (knockout, KO) of specific genes required for organ 
development in utero, pigs could be used as bioreactors for production of donor-specific 
organs/tissues by a process called blastocyst complementation or exogenic organ production. 
This is theoretically applied by injection of induced pluripotent stem cells (iPSCs) into a 
KO-pig blastocyst from which the donor cells fill the vacant developmental niche, resulting 
in a human organ to match the donor. This would be analogous to an autograft, which 
will avoid immune responses when transplanted into a patient. Likewise, pigs are far closer 
to humans in physiology than other commonly used model animals.
Gene editing allows production of animals with specific conditions that mimic 
 human disorders, which will allow more-accurate pre-clinical evaluation of novel drugs 
and advanced medical devices before human clinical trials. The most dramatic promise 
of gene-edited animals is in agriculture worldwide. In the Anthropocene era (Vince, 
2011), characterized by global changes in climate with attending alterations in spreads 
of animal-disease vectors, the exchange of new genes (traits) from different breeds in 
Figure 2. Crops and animals modified by molecular genetics procedures (GM) 
 approved for agricultural purposes. No government-approved GM animal has been 
developed for agricultural use.
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 various regions and microenvironments of the world will be vital for adaptation of ani-
mals and their abilities to provide improved nutrition while simultaneously improving 
their welfare. Additionally, gene editing will allow novel tweaking of genomes in order to 
introduce new approaches to the control of animal diseases as well as to improve animal 
health and efficiency.
The three major technologies for introducing site-specific double-stranded DNA breaks 
into genomes—zinc finger nucleases, ZFNs, transcription activator-like element nucle-
ases, TALENs, and RNA-guided endonucleases, RGENs, of which the CRISPR-Cas9 
system is best known (Gaj et al., 2013; Kim and Kim, 2014)—are effective in livestock 
genomes (Carlson et al., 2012; Tan et al., 2013). The steps for creating livestock with 
specific genome-edits are illustrated in Figure 4. The process begins with introducing 
double-strand DNA breaks in the genomes of somatic cells, typically fetal fibroblasts, 
expanding the cells into colonies that then are screened for the desired outcomes. This 
process is between 10% and 70% efficient, depending on the gene, the size of the edit, 
the genetic locus and cell type. Counter-intuitively, introducing single-nucleotide changes 
is generally less efficient than introducing longer alterations (Tan et al., 2013). Table I 
shows the approximate efficiencies of introducing defined gene edits into the genomes 
of pigs, cattle, goats and sheep.
Figure 3. Promise of gene-edited animals. The major areas of application are, from 
left to right, 1) improved animal genomes adapted to local environmental conditions 
to produce food more efficiently, 2) improved animal models of human disease that 
 provide more reliable pre-clinical information regarding safety of new drugs and 
 medical devices, and 3) animals designed to harbor patent-specific organs, tissues and 
cells for transplantation that will not induce adverse immune responses.
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The POLLED gene in cattle illustrates the power of gene editing in large animals. Dairy 
cattle, like many other mammals, naturally have horns. Early in the domestication process 
of dairy cattle thousands of years ago, horns were valuable for survival, whereas today horns 
have no intrinsic value because the animals are confined to secure enclosures. However, 
horns do pose a significant risk both to the animals and to humans because of inadvertent 
nicking and, consequently, are removed efficiently and cost-effectively, but not without 
suffering (Graf and Senn, 1999). Two mutations that prevent development of horns in 
certain breeds of cattle have been mapped on the bovine genome (Medugorac et al., 2012; 
Seichter et al., 2012) that may encode an lncRNA rather than a protein (Allais-Bonnet 
Figure 4. Route of obtaining gene-edited livestock (pigs). 1) Introduced gene-edits into 
fetal fibroblasts (1 month; 10–70% efficiency). 2) Transfer validated gene-edited cells 
into enucleated oocytes. 3) Activate embryos by electrical pulse to fuse the cell with the 
oocyte. 4) Transfer activated embryos into surrogate female to produce 5) F0 pigs with 
the desired gene-edit (4–9 months; 1–5% efficiency).
• >98% success (60+ genes/loci successfully targeted; 1 failure
• Heterozygosity (monoallelic conversion) up to 70%
• Homozygosity (biallelic conversion) up to 40%
• Single-nucleotide polymorphism(SNP) edits with 1 bp alteration 
 about 10% efficiency
• SNP edits much more efficient with silent mutations
Table I. Summary of homology-directed recombination for livestock fibroblasts.
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et al., 2013). The standard method for introducing POLLED in dairy breeds would be 
by crossing with a hornless breed (Figure 5), but that produces a hornless animal without 
the best combination of traits for the dairy industry. Recovering the dairy merits would 
take nearly a quarter century of backcrossing and selection.
Gene editing saves about eight generations of backcrossing and the entire attendant 
screening for alleles desirable to industry. Figure 6 shows molecular introgression of 
POLLED into the Hereford breed. The efficiency of introducing this particular site-spe-
cific mutation with this particular pair of TALENs was 1% to 5%, substantially below 
the average rate shown in Table I. However, because the genomic edits can be introduced 
into the chromosomes of fibroblasts, even this relatively low rate is sufficiently high for 
easy selection of appropriate genomes for transfer into embryos.
Gene editing is not limited to single changes. Because of the high efficiency of the 
procedure, multiple selected mutations can be simultaneously introduced into genomes. 
Thus, gene editing offers parallel, precise changes in genomes of animals rather than 
sequential changes. This can save decades of time. Moreover, as illustrated by the recent 
elucidation of the genetic basis of POLLED, as greater numbers of genomes of vari-
ous breeds of livestock are sequenced, our abilities to identify further traits conferring 
 disease-resistance, drought-tolerance, temperature-tolerances (high and low), etc., will be 
enhanced. All findings of this sort will provide a bank of alleles for molecular introgression. 
The process is fast, efficient, and essentially unlimited in the combinations of traits that 
can be moved as needed. In the coming decades, in which significant variations in global 
as well as local environmental conditions are predicted, gene editing offers the ability 
to substantially expand the diversity of animals that will be better adapted for climatic 
Figure 5. Introgression of the POLLED allele into dairy cattle. Top: Merits for traits 
of commercial value are shown by the circles for dairy (left) and beef (right) breeds. 
The POLLED locus is shown by the P (or h for the Hereford breed) on chromosome 1 
(BTA1) for the two breeds. Bottom: Cross-breeding to introgress P into a dairy back-
ground will mix all the valued traits for both breeds. Alternatively, gene editing of the 
h locus to introduce the P allele maintains the dairy merits.
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changes. This will benefit the animals as well as their caretakers and the populations that 
depend on agricultural production. The promise of gene editing in livestock is enormous 
(Howe et al., 2008).
Challenges for Gene Editing in Animals
The challenge for application of gene editing in animals is evident from Figure 2: not 
a single commercial animal for agricultural purposes has been approved in the United 
States. Regulatory reluctance to issue approval for the first proposed commercial animal, 
faster-growing salmon, has been stymied by regulatory delays (Figure 7) (Van Eenennaam 
and Muir, 2011; Maxmen, 2012b; Ledford, 2013; Editorial, 2014). There are suggestions 
that molecular introgression using the procedures described above will meet the same 
regulatory purgatory (Maxmen, 2012a). One way of appreciating the consequences of 
regulatory reluctance to approve any genetically modified livestock are the hundreds of 
citations on genetically modified animals 10–20 years ago, reviewed by Tan et al. (2012), 
compared with the paucity of citations today. If there is no method of gaining approval, 
there is no incentive for development.
The letters (many form) about the transgenic salmon on FDA’s website1raised the same 
concerns listed above (p. 40) for transgenic organisms in general:
• Health effects—possibly allergic responses to a transgenic product, but more 
commonly general uncertainty in what eating a transgenic food might mean over 
many years.
Figure 6. Molecular introgression of the POLLED allele into dairy cattle by gene 
 editing. A double-stranded oligonucleotide serves as a template for homology-directed 
recombination (HDR) following introduction of a double-stranded DNA break (DSB) 
in the genome following cleavage by a specific pair of TALENs. Because gene-editing is 
precise, genomes can be screened by PCR for exactly the desired changes.
F1, F2, R1 and R2 are specific DNA oligonucleotide primers for PCR analysis.
1http://www.regulations.gov/#!docketBrowser;rpp=25;po=0;dct=PS;D=FDA-2011-N-0899.
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• Environmental effects—diversity may be reduced and/or transgenic animals may 
take over ecosystems.
• Social effects—transgenic products come from large corporations catering to large 
farms that dominate over smaller “family” farms; hence, greedy corporations 
benefit at the expense of consumers.
• Moral concerns—tampering or tinkering with nature, often referred to as “playing 
God.”
Regulatory agencies may take emotional reactions of citizens into consideration in deci-
sions, but the primary driver should always be scientific understanding. In that light, what 
have we learned from thirty years (and more than $100 billion) of molecular genetics and 
agricultural research, much of which can be understood by the large investment into the 
molecular, cellular and developmental biology of humans, which represent a pretty good 
model system for livestock?
Health Effects
Regarding health effects, if a genetic alteration is not detrimental to the animal, it is 
highly unlikely it would be to humans. The many cultures and societies of humans 
eat almost every type of life form. All food is foreign to someone, but not necessarily 
unhealthy. Generally it is processing of food, not the original product that can lead to 
adverse health effects. Regulatory pandering to public fears of food safety (DeFrancesco, 
2013) must change.
Environmental Effects
Environmental effects for gene-edited animals will be no different from any other intro-
duction of a related animal; the changes are too minor. For instance, although there are 
peer-reviewed studies that suggest ecological disaster from escape of even a few geneti-
cally altered fish (Muir and Howard, 2002; Devlin et al., 2006) hundreds of thousands 
of farmed fish escape from Norwegian fisheries with little discernable effect (Glover et 
al., 2012; Skilbrei et al., 2014). There is theory and there is the real world, which often 
goes ignored (Hackett, 2002; Fedoroff, 2013). More importantly, as noted earlier, gene 
editing offers the opportunity of introducing far greater diversity into ecosystems because 
it is so economically efficient that it can be used by mega-farms and even the smallest 
family farm in a unique micro-ecosystem where agricultural efficiency can bring the 
greatest benefits. 
Figure 7. Year-after-year delays in approval of transgenic salmon by the FDA.
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Social Effects
The issue of huge corporations dominating the availability of genetically modified products 
is in large part a direct consequence of the cumbersome regulatory processes that take 
years for approval, if they come at all. That is, governmental policy demands expenditures 
of millions of dollars for regulatory approval that only large companies can afford.
Moral Concerns
Moral concerns are beyond the scope of most scientific discourses. But, an often-over-
looked point on this issue is that genetic modifications with modern techniques are mere 
engineering, not creation. 
Regulatory Issues
Regulatory problems are far greater than just addressing the common concerns above. 
The regulatory system is designed to fail (Figure 8). It begins with the notion that the 
procedure for introducing genetic alteration is a greater issue than the outcome. That is 
completely based on fears in the 1980s about the unknowns of genetic engineering. That 
attitude has remained in place for thirty years, even though our understanding and our 
techniques have advanced beyond what was imaginable back then. A second problem is 
that scientists thrive on conducting experiments to address unresolved scientific ques-
tions. However, lab testing has severe cost and infrastructural constraints that restrict the 
numbers of animals and minimize the variations and conditions that can be considered. 
In contrast, the natural world is characterized by large numbers of organisms, innumerable 
variables, and confounding interactions that are poorly understood. Hence, singling out 
and testing only a few of the myriad variables inevitably leads to irrelevant results that, 
because they are so controlled and do provide reproducible results, are often published in 
premier journals. The result is that the question remains unanswered for which, ironically, 
the scientists are rewarded: more publications and more work. Regulators are also rewarded; 
they recognize that issues brought up by the scientific community remain unresolved and, 
thereby, no decision needs to be made. The results are evident. No genetically modified 
animals derived from modern genetic techniques have passed regulatory approval. 
Broken Partnership
Gene editing represents the ultimate level of genetic engineering wherein precise changes 
can be made in genomes to achieve exact goals. The old ways of looking at genetic engi-
neering are outdated. Regulators and their advisors must update and apply new ways of 
evaluating the coming tidal wave of gene-edited animals. The partnership between the 
regulatory agencies and the funding agencies is broken. The new tools, understanding 
and approaches to improve agricultural efficiency to meet needs of the 21st century have 
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